Visiomed Group SA Share Price
Equities
ALVMG
FR0013481835
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1844 EUR | +2.56% | -6.40% | -34.84% |
05-31 | Visiomed: significant debt reduction | CF |
03-26 | Visiomed: share price rises on 'record' 2023 results | CF |
Sales 2021 | 7.18M 7.79M 611M | Sales 2022 | 14.44M 15.67M 1.23B | Capitalization | 98.55M 107M 8.39B |
---|---|---|---|---|---|
Net income 2021 | -4M -4.34M -341M | Net income 2022 | -5M -5.42M -426M | EV / Sales 2021 | 1.38 x |
Net cash position 2021 | 1.62M 1.75M 138M | Net Debt 2022 | 3.26M 3.53M 277M | EV / Sales 2022 | 7.05 x |
P/E ratio 2021 |
-1.33
x | P/E ratio 2022 |
-22.7
x | Employees | 73 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 98.94% |
1 day | +2.56% | ||
1 week | -6.40% | ||
1 month | -1.50% | ||
3 months | -26.36% | ||
6 months | -43.26% | ||
Current year | -34.84% |
Managers | Title | Age | Since |
---|---|---|---|
Clement Pacaud
CEO | Chief Executive Officer | 34 | 01-21 |
Investor Relations Contact | - | - | |
Thomas Picquette
SEC | Corporate Secretary | - | 31/03/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | - | - | |
Thomas Picquette
SEC | Corporate Secretary | - | 31/03/22 |
Anne Gaignard
BRD | Director/Board Member | - | 31/03/22 |
Date | Price | Change | Volume |
---|---|---|---|
31/05/24 | 0.1844 | +2.56% | 911,513 |
30/05/24 | 0.1798 | +2.16% | 1,723,357 |
29/05/24 | 0.176 | -8.81% | 2,086,935 |
28/05/24 | 0.193 | -0.52% | 464,807 |
27/05/24 | 0.194 | -1.52% | 165,105 |
Real-time Euronext Paris, May 31, 2024 at 04:35 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-34.84% | 61.48M | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B |
- Stock Market
- Equities
- ALVMG Stock